Oura's May 2026 confidential S-1 filing after its $11 billion Series E valuation has created a wide distribution of implied IPO market caps, as traders weigh rapid revenue expansion against elevated multiples in a crowded 2026 IPO calendar that includes SpaceX and OpenAI. The company doubled revenue to roughly $500 million in 2024 and is tracking toward $1.5–2 billion in 2026 sales through subscription membership growth and new AI-driven health features, yet this implies forward multiples of 5–10x that could compress or expand depending on profitability disclosure, market sentiment, and Treasury yields at pricing. The near-even spread across $7.5–20 billion+ bins, plus an 11.5% probability of no IPO before January 2027, reflects uncertainty over SEC review timing, comparable health-tech precedents, and potential shifts in risk appetite for high-growth medtech names.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日$10B–$12.5B 14%
$20B+ 14%
$15B–$17.5B 13%
$17.5B–$20B 12%
$177,758 Vol.
$177,758 Vol.
<$7.5B
8%
$7.5B–$10B
11%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
13%
$17.5B–$20B
12%
$20B+
14%
No IPO before January 2027
10%
$10B–$12.5B 14%
$20B+ 14%
$15B–$17.5B 13%
$17.5B–$20B 12%
$177,758 Vol.
$177,758 Vol.
<$7.5B
8%
$7.5B–$10B
11%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
13%
$17.5B–$20B
12%
$20B+
14%
No IPO before January 2027
10%
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
マーケット開始日: May 26, 2026, 12:28 PM ET
Resolver
0x69c47De9D...If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Resolver
0x69c47De9D...Oura's May 2026 confidential S-1 filing after its $11 billion Series E valuation has created a wide distribution of implied IPO market caps, as traders weigh rapid revenue expansion against elevated multiples in a crowded 2026 IPO calendar that includes SpaceX and OpenAI. The company doubled revenue to roughly $500 million in 2024 and is tracking toward $1.5–2 billion in 2026 sales through subscription membership growth and new AI-driven health features, yet this implies forward multiples of 5–10x that could compress or expand depending on profitability disclosure, market sentiment, and Treasury yields at pricing. The near-even spread across $7.5–20 billion+ bins, plus an 11.5% probability of no IPO before January 2027, reflects uncertainty over SEC review timing, comparable health-tech precedents, and potential shifts in risk appetite for high-growth medtech names.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日


外部リンクに注意してください。
外部リンクに注意してください。
よくある質問